Bradenton, FL-based HP Ingredients Corp. announced that its NeuroActin Andrographis ingredient received a patent for its use in brain health supplements. The patent is entitled, “Treatment of Alzheimer’s and Cognitive Impairment with Andrographolides,” and describes how the ingredient “was found to prevent and reverse neuropathology and stimulates neurogenesis.” The ingredient was found to activate Wnt signaling and inhibit GSK-3b, an enzyme that regulates the Wnt signaling pathway.
Boston, MA—A group of researchers from various institutions including Harvard T. H. Chan School of Public Health, Brown University and Harvard Medical School have published a study in JAMA Ophthalmology suggesting that certain nutrients may lower the risk of developing age-related macular degeneration (AMD).
East Windsor, NJ—A new comprehensive book about curcumin is now available. Written by Muhammed Majeed, Ph.D., founder of Sabinsa Corp., and co-authors, Curry Powder to Clinical Significance (NutriScience Publishers, 2015) discusses the clinical use of curcumin and the history of Sabinsa’s Curcumin C3 Complex.